Sign in
4

Changes in Ownership

Relay Therapeutics, Inc. Filed Acc 0001209191-24-002472

Chief Financial Officer sold 2,005 shares at $9.64 ($19,328)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Catinazzo Thomas Chief Financial Officer 2024-01-29 Sale −2,005 $9.64 $19,328 341,846 D
Open-market sales · 2,005 sh · avg $9.64 · $19,328
Loading xslF345X05/doc4.xml…